This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Find out more here.
You are not logged in
08.30-17.30
Testosterone replacement therapy in hypogonadal men with Type 2 diabetes: an interactive case-based discussion with an expert panel
Bayer Healthcare
Central 5
18.30-19.45
DKA prevention: best models of practice
Menarini Diagnostics
Central 7
18.30-20.00
Diabetes Question Time: insulin without compromise? Novo Nordisk Exchange Auditorium 18:30-21:00
READ ALL ABOUT IT! Have I got “Diabetes” news for you?
Charter 2-3
18.30-22.30
New directions in the treatment of Type 2 diabetes: what you need to know about the SGLT2 inhibitor FORXIGA (dapagliflozin)
Charter 2
08.00-09.30
Less talk, more action: making Peer Support work in your health settingDiabetes UK
Charter 4
Personalising the use of GLP-1 receptor agonist therapies: evidence and practicalities
18.15-20.30
You will need to download the free Adobe Acrobat reader to view PDF files.
Save pages and print in one go.
What is this?